Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AmpliMed Corporation
ClinicalTrials.gov Identifier:
NCT00327288
First received: May 17, 2006
Last updated: June 22, 2015
Last verified: June 2015